These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 749192)

  • 1. [Curability of advanced malignant lymphoma under conditions of modern combination chemotherapy].
    Viollier AF; Senn HJ; Obrecht JP
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1958-61. PubMed ID: 749192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
    Viollier AF; Senn HJ
    Schweiz Med Wochenschr; 1976 May; 106(22):730-42. PubMed ID: 996491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
    Klener P; Donner L; Roth Z
    Neoplasma; 1976; 23(3):315-22. PubMed ID: 958533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
    Weick JK; Jones SE; Haut A; Fisher R; Dixon D
    Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of betamethasone in polychemotherapy of lymphoproliferative diseases].
    Cellerino R; Ambrosetti A; Tummarello D; Perini A; Piga A; Celebrano M
    Minerva Med; 1980 Sep; 71(32):2293-7. PubMed ID: 6933321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of malignant lymphoma].
    Horikoshi N; Ogawa M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1903-10. PubMed ID: 6985187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
    Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of malignant lymphomas].
    Huber H; Gattringer C; Lechleitner M; Gyenes T; Frommhold H; Brittinger G; Braunsteiner H
    Wien Klin Wochenschr; 1983 Feb; 95(4):93-112. PubMed ID: 6342274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphoma.
    Goldhirsch A; Pirovino M; Sonntag RW; Tschopp L; Ryssel HJ; Brunner KW
    Cancer Treat Rep; 1980; 64(2-3):335-7. PubMed ID: 6157468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of non-Hodgkin's lymphomas].
    Stacher A; Heinz R
    Wien Klin Wochenschr; 1982 Sep; 94(16):415-21. PubMed ID: 6755923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Salvage chemotherapy in resistant malignant lymphomas (author's transl)].
    Tursz T; Ben Ayed F; Droz JP; Spielmann M; Amiel JL
    Bull Cancer; 1982; 69(1):28-32. PubMed ID: 6176284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of therapy in Hodgkin's disease with special reference to polychemotherapy (MOPP)].
    Büchi G; Cervellera M; Vigna-Taglianti G; Denna V; Navone R
    Minerva Med; 1976 Dec; 67(59):3913-20. PubMed ID: 826854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-Hodgkin lymphoma in patients with Hodgkin's disease].
    Somers R; van Heerde P
    Ned Tijdschr Geneeskd; 1983 Jan; 127(2):55-9. PubMed ID: 6828172
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current status of chemotherapy in the treatment of malignant lymphomas].
    Ohnoshi T; Hayashi K; Ueno K; Tada A; Murashima M; Mizuta J; Tagawa S; Kimura I
    Gan To Kagaku Ryoho; 1989 May; 16(5):1989-96. PubMed ID: 2658838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of malignant lymphomas].
    Oyama A; Ota K
    Gan No Rinsho; 1988 Apr; 34(5):565-71. PubMed ID: 3385922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Curability of malignant neoplasms: value and limitations of chemotherapy].
    Alberto P
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1930-4. PubMed ID: 219468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress of radiation therapy in malignant lymphomas].
    Kaneta K; Nakazawa N; Kawabata K; Hashida J; Kawaguchi T; Yamashita T
    Gan No Rinsho; 1988 Apr; 34(5):555-64. PubMed ID: 3385921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.